VT-464
VT-464 is a nonsteroidal antiandrogen (NSAA) which is under development by Innocrin Pharmaceuticals for the treatment of prostate cancer. It is a CYP17A1 inhibitor and by extension a steroidogenesis inhibitor that is structurally related to the approved medication abiraterone acetate, but that, unlike abiraterone acetate, does not increase mineralocorticoid production.
Pharmacology[edit | edit source]
VT-464 is a lyase-selective CYP17A1 inhibitor, meaning that it selectively inhibits the lyase activity of CYP17A1. This is in contrast to non-selective CYP17A1 inhibitors like abiraterone acetate, which inhibit both the hydroxylase and lyase activities of CYP17A1. As a result of its selectivity for inhibition of CYP17A1 lyase, VT-464 does not increase mineralocorticoid production, and hence, does not require concomitant administration of a glucocorticoid like prednisone to prevent mineralocorticoid excess syndrome.
Clinical trials[edit | edit source]
As of 2016, VT-464 is in phase II clinical trials for prostate cancer. Preliminary results have been promising, with a high rate of biochemical response and a favorable safety profile.
See also[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
